This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Evaluating the Effects of Antipsychotics on Cognition in Schizophrenia

Collaborative Working Group on Clinical Trial Evaluations

Published: June 1, 1998

Article Abstract

Cognitive deficits are an integral feature of schizophrenia and have a deleterious effect on the abilityof schizophrenic patients to work and function in a social environment. Drugs that bring about substantialcognitive improvement represent a major contribution in improving the quality of life inschizophrenia. Recent studies have suggested that the atypical antipsychotics may be more useful thanconventional agents for improving cognition. There is evidence that scores on neuropsychological assessmentshave improved after treatment with clozapine, risperidone, and quetiapine. Future researchis needed to characterize and quantify the cognitive effects of the atypical antipsychotics.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...